Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Press Release
November 01, 2011
WASHINGTON, D.C. (October 31, 2011) — Scores of new medicines and other medical products to treat deadly diseases in poor countries are caught in a regulatory labyrinth that slows approvals, raises costs and sometimes puts patients at risk, according to a new report from the Center for Global Develo...